Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) (Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF)) (Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF)) - Lindy Durrant CEO at the Proactive One2One Forum
Scancell Holdings PLC is developing novel immunotherapies for the treatment of cancer based on its technology platforms, ImmunoBody®, Moditope® and AvidiMabTM, with four products in multiple cancer indications and development of a vaccine for COVID-19.